Biotech 20lab

Network Immunology Inc.

Entirely novel immune system modification technology platform for allergy immuno-therapy.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Vancouver, BC, Canada
  • Currency CAD
  • Founded June 2003
  • Employees 10
  • Incorporation Type Other
  • Website

Company Summary

Network Immunology is developing a platform technology for allergy immuno-therapy.

Our plan is to license our technology and product to a large Biotech or Pharma company.


  • Default avatar
    George Hoffmann
    President and CEO

  • Default avatar
    Geoffrey Hoffmann
    Chairman and Chief Scientist

  • Default avatar
    Jonathan Willmer


Previous Investors